首页> 外文OA文献 >Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence
【2h】

Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence

机译:干扰素-利巴韦林联合治疗对丙型肝炎病毒复发的肝移植患者的持续应答后,肝组织中丙型肝炎病毒RNA的长期组织学改善和清除

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and objective: A proportion of liver transplanted patients with recurrent chronic hepatitis have a sustained virological response to combination therapy with interferon plus ribavirin. However, the long term benefit of antiviral therapy with regard to hepatitis C virus (HCV) RNA clearance remains unknown in patients with HCV recurrence. This study examined the long term biochemical, virological, and histological outcome in transplanted patients with recurrent chronic hepatitis who had a sustained virological response to antiviral therapy.
机译:背景与目的:一部分肝移植复发性慢性肝炎患者对干扰素联合利巴韦林的联合治疗具有持续的病毒学应答。然而,对于丙型肝炎病毒复发的患者,抗病毒治疗对丙型肝炎病毒(HCV)RNA清除的长期益处仍然未知。这项研究检查了对慢性病毒性肝炎的移植患者的长期生化,病毒学和组织学结果,这些患者对抗病毒治疗具有持续的病毒学应答。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号